Heerlen, Netherlands, May 7, 2014 (GLOBE NEWSWIRE) -- The DSM Annual General Meeting of Shareholders on 7 May 2014 passed a resolution to declare a dividend for 2013 of €1.65 per ordinary share of €1.50 par value. An interim dividend of €0.50 per ordinary share having been paid on 29 August 2013, the final dividend for 2013 will amount to €1.15 per ordinary share. With the passing of the resolution by the AGM, and in line with DSM's policy to provide a stable and preferably rising dividend, 2013 marks the fourth consecutive year DSM's dividend has been increased.
This final dividend of €1.15 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE Euronext will be 9 May 2014 and the record date will be 13 May 2014.
Shareholders have from 14 May until 27 May 2014 (3.00 pm CET) to indicate their choice. On 28 May 2014 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.
This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on 21 May 2014 up to and including 27 May 2014. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2014 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext.
The following timetable applies:
9 May 2014: Ex-dividend quotation
13 May 2014: Record Date
14 May 2014 - 27 May 2014(3.00 pm CET): Period in which shareholders can indicate their choice
28 May 2014 (COB): Announcement of the exchange ratio
3 June 2014: Delivery of shares or cash payment
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
| DSM Corporate Communications Herman Betten |
tel. +31 (0) 455782017
| DSM Investor Relations Dave Huizing |
tel. +31 (0) 45 5782864
Press release-pdf http://hugin.info/130663/R/1783576/610847.pdf